These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 10433497)
1. Effect of protein kinase C and phospholipase A2 inhibitors on the impaired ability of human diabetic platelets to cause vasodilation. Oskarsson HJ; Hofmeyer TG; Coppey L; Yorek MA Br J Pharmacol; 1999 Jun; 127(4):903-8. PubMed ID: 10433497 [TBL] [Abstract][Full Text] [Related]
2. Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. Ramana KV; Friedrich B; Tammali R; West MB; Bhatnagar A; Srivastava SK Diabetes; 2005 Mar; 54(3):818-29. PubMed ID: 15734861 [TBL] [Abstract][Full Text] [Related]
3. Effect of inhibition of aldose reductase on glucose flux, diacylglycerol formation, protein kinase C, and phospholipase A2 activation. Keogh RJ; Dunlop ME; Larkins RG Metabolism; 1997 Jan; 46(1):41-7. PubMed ID: 9005967 [TBL] [Abstract][Full Text] [Related]
4. Diabetic human platelets release a substance that inhibits platelet-mediated vasodilation. Oskarsson HJ; Hofmeyer TG Am J Physiol; 1997 Jul; 273(1 Pt 2):H371-9. PubMed ID: 9249512 [TBL] [Abstract][Full Text] [Related]
5. Identification of the mechanism for the inhibition of Na+,K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. Xia P; Kramer RM; King GL J Clin Invest; 1995 Aug; 96(2):733-40. PubMed ID: 7635966 [TBL] [Abstract][Full Text] [Related]
6. 24,25-(OH)2D3 regulates protein kinase C through two distinct phospholipid-dependent mechanisms. Helm S; Sylvia VL; Harmon T; Dean DD; Boyan BD; Schwartz Z J Cell Physiol; 1996 Dec; 169(3):509-21. PubMed ID: 8952700 [TBL] [Abstract][Full Text] [Related]
7. Platelets from patients with diabetes mellitus have impaired ability to mediate vasodilation. Oskarsson HJ; Hofmeyer TG J Am Coll Cardiol; 1996 May; 27(6):1464-70. PubMed ID: 8626959 [TBL] [Abstract][Full Text] [Related]
8. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation. Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154 [TBL] [Abstract][Full Text] [Related]
9. 1,25(OH)2D3 regulates protein kinase C activity through two phospholipid-dependent pathways involving phospholipase A2 and phospholipase C in growth zone chondrocytes. Sylvia VL; Schwartz Z; Curry DB; Chang Z; Dean DD; Boyan BD J Bone Miner Res; 1998 Apr; 13(4):559-69. PubMed ID: 9556056 [TBL] [Abstract][Full Text] [Related]
10. Interrelated effects of insulin and glucose on diacylglycerol-protein kinase-C signalling in rat adipocytes and solei muscle in vitro and in vivo in diabetic rats. Hoffman JM; Ishizuka T; Farese RV Endocrinology; 1991 Jun; 128(6):2937-48. PubMed ID: 2036970 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporine impairs the ability of human platelets to mediate vasodilation. Oskarsson HJ; Hofmeyer TG; Olivari MT Hypertension; 1997 Jun; 29(6):1314-21. PubMed ID: 9180635 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Zhang SL; Filep JG; Hohman TC; Tang SS; Ingelfinger JR; Chan JS Kidney Int; 1999 Feb; 55(2):454-64. PubMed ID: 9987070 [TBL] [Abstract][Full Text] [Related]
13. Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro. Assert R; Scherk G; Bumbure A; Pirags V; Schatz H; Pfeiffer AF Diabetologia; 2001 Feb; 44(2):188-95. PubMed ID: 11270675 [TBL] [Abstract][Full Text] [Related]
14. Diacylglycerol stimulates the Ca2(+)-dependent phospholipase A2 of ram spermatozoa. Roldan ER; Mollinedo F Biochem Biophys Res Commun; 1991 Apr; 176(1):294-300. PubMed ID: 2018523 [TBL] [Abstract][Full Text] [Related]
15. Preferential involvement of a phospholipase A2-dependent pathway in CD69-mediated platelet activation. Testi R; Pulcinelli FM; Cifone MG; Botti D; Del Grosso E; Riondino S; Frati L; Gazzaniga PP; Santoni A J Immunol; 1992 May; 148(9):2867-71. PubMed ID: 1315360 [TBL] [Abstract][Full Text] [Related]
16. A functional interaction between TRPC/NCKX induced by DAG plays a role in determining calcium influx independently from PKC activation. Pulcinelli FM; Trifirò E; Massimi I; Di Renzo L Platelets; 2013; 24(7):554-9. PubMed ID: 23249278 [TBL] [Abstract][Full Text] [Related]
17. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. Tesfamariam B; Brown ML; Cohen RA J Clin Invest; 1991 May; 87(5):1643-8. PubMed ID: 2022734 [TBL] [Abstract][Full Text] [Related]
18. Thrombin- and cathepsin G-induced platelet aggregation: effect of protein kinase C inhibitors. Puri RN; Colman RW Anal Biochem; 1993 Apr; 210(1):50-7. PubMed ID: 7683848 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Xia P; Inoguchi T; Kern TS; Engerman RL; Oates PJ; King GL Diabetes; 1994 Sep; 43(9):1122-9. PubMed ID: 8070612 [TBL] [Abstract][Full Text] [Related]
20. Involvement of phospholipase C-gamma2 in activation of mitogen-activated protein kinase and phospholipase A2 by zooxanthellatoxin-A in rabbit platelets. Rho MC; Nakahata N; Nakamura H; Murai A; Ohizumi Y J Pharmacol Exp Ther; 1997 Jul; 282(1):496-504. PubMed ID: 9223592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]